Immunogenicity and safety of conventional influenza vaccine in patients with type 2 diabetes
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0001423
- Lead Sponsor
- Transgovernmental Enterprise for Pandemic Influenza in Korea
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 236
Inclusion Criteria
Diabetes and healthy adults aged 19 and over
Written informed consent obtained from the subject
Exclusion Criteria
known allergy to egg, presentation of any febrile illness =37.5°C on the day of vaccination, any history of hypersensitivity reaction to previous influenza vaccination, any other vaccinations within the past one month, use of immunosuppressive agent, recipient of blood product or immunoglobulins during the previous three months, and any other conditions that might interfere with the study results.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Geometric Mean Titers (GMTs) of Haemagglutination Inhibition (HI) Antibodies Against Agripal Vaccine Strains;Geometric Mean Titers (GMTs) of Haemagglutination Inhibition (HI) Antibodies Against Agripal Vaccine Strains ;Geometric Mean Titers (GMTs) of Haemagglutination Inhibition (HI) Antibodies Against Agripal Vaccine Strains
- Secondary Outcome Measures
Name Time Method umber of Subjects With Solicited Local and General Symptoms After Administration of Agripal